Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune landscapes in patients with gastric adenocarcinoma

被引:0
|
作者
Hong, Haidu [1 ]
Huang, Yuancheng [2 ,3 ]
Yang, Zehong [4 ]
Jiang, Xiaotao [4 ]
Liu, Hong [5 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Southern Med Univ, Dongguan Peoples Hosp, Dept Oncol, Affiliated Hosp 10, Dongguan 523000, Guangdong, Peoples R China
[3] Southern Med Univ, Dongguan Peoples Hosp, Canc Ctr, Affiliated Hosp 10, Dongguan 523000, Guangdong, Peoples R China
[4] Guangzhou Univ Chinese Med, Clin Med Coll 1, Guangzhou 510405, Guangdong, Peoples R China
[5] Guangdong Pharmaceut Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Gonghexiheng St 1, Guangzhou 510080, Guangdong, Peoples R China
关键词
Gastric adenocarcinoma; Pyroptosis; Long non-coding RNAs; Prognostic signature; Tumor microenvironment; Immunotherapy; NONCODING RNAS; EXPRESSION;
D O I
10.1007/s12672-024-01579-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectivesThe purpose of this study was to investigate the significance of pyroptosis-related lncRNAs (PRlncRNA) in predicting prognoses and immune landscapes of patients with gastric adenocarcinoma (STAD).MethodsTranscriptomic data and clinicopathological data were obtained from The Cancer Genome Atlas database. Based on correlation analysis and univariate Cox regression, prognostic PRlncRNA were identified. Subsequently, a PRlncRNA prognostic signature (PRLPS) was generated via least absolute shrinkage and selection operator (LASSO) regression, Kaplan-Meier method, receiver operating characteristic (ROC) curves, principal component analysis, and univariate and multivariate regression. Besides, the clinicopathological characteristics, tumor microenvironment (TME) scores, the immune landscapes in different risk subgroups were explored. Moreover, based on three PRlncRNA, we constructed a competing endogenous RNA (ceRNA) network. Additionally, Gene Set Enrichment Analysis (GSEA), Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) and Gene Ontology (GO) analysis were performed for biological functional analysis based on the difference between high- and low- risk groups, which also used to screen out potential STAD drugs.Results21 PRlncRNA made up the prognostic signature, which had significant value in predicting the overall survival (OS), clinicopathological features, TME, immune checkpoint genes expression, and the response to immune checkpoint inhibitors of patients with STAD. In a addition, we constructed a ceRNA network comprising 3 PRlncRNAs and 69 mRNAs. The function of PRlncRNA was related to cancer-associated pathways. Ten small molecular drugs that might improve the prognosis of patients were screened out by connectivity maps.ConclusionsUsing PRlncRNA as a prognostic indicator for STAD, we identified predictive biomarkers and immunotherapy targets while refreshing our understanding.
引用
收藏
页数:21
相关论文
共 50 条
  • [11] A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma
    Zhao, Kai
    Li, Xiangyu
    Shi, Yuanxin
    Lu, Yun
    Qiu, Peng
    Deng, Zhengdong
    Yao, Wei
    Wang, Jianming
    FRONTIERS IN GENETICS, 2022, 13
  • [12] Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma
    Gong, Zetian
    Li, Qifan
    Yang, Jian
    Zhang, Pengpeng
    Sun, Wei
    Ren, Qianhe
    Tang, Junjie
    Wang, Wei
    Gong, Hui
    Li, Jun
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [13] Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Gastric Cancer
    Jiang, Min
    Fang, Changyin
    Ma, Yongping
    BIOMOLECULES, 2023, 13 (03)
  • [14] Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung Metastasis
    Liu, Li
    Chen, Chenxi
    Tu, Gang
    Peng, Yang
    Shen, Meiying
    Xu, Yingkun
    Liu, Shengchun
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [15] Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
    Zeng, Ruijie
    Huang, Shujie
    Qiu, Xinqi
    Zhuo, Zewei
    Wu, Huihuan
    Jiang, Lei
    Sha, Weihong
    Chen, Hao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [16] Mitochondrial Homeostasis-Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
    Peng, Bo
    Lou, Han
    Chen, Chen
    Wang, Lei
    Li, Huawei
    Lu, Tong
    Na, Ruisi
    Xu, Ran
    Xin, Tong
    Yao, Lingqi
    Xu, Henghui
    Wang, Kaiyu
    Liu, Xin
    Zhang, Linyou
    FRONTIERS IN GENETICS, 2022, 13
  • [17] Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma
    Tan, Yuying
    Lu, Liqing
    Liang, Xujun
    Chen, Yongheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [18] Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma
    Yuying Tan
    Liqing Lu
    Xujun Liang
    Yongheng Chen
    World Journal of Surgical Oncology, 20
  • [19] A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma
    Chen, Zhiyuan
    Han, Zheng
    Nan, Han
    Fan, Jianing
    Zhan, Jingfei
    Zhang, Yu
    Zhu, He
    Cao, Yu
    Shen, Xian
    Xue, Xiangyang
    Lin, Kezhi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [20] Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
    Huang, Qianrong
    Yan, Jun
    Jiang, Qian
    Guo, Fangzhou
    Mo, Ligen
    Deng, Teng
    MEDICINE, 2023, 102 (06)